Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's ...

Gallup’s latest health index links the rapid rise of semaglutide and similar injectables to measurable population-level weight loss.

Until recently, GLP -1s, a powerful new class of weight-loss drugs, were confined mostly to rich countries. Yet the World ...

Semaglutide, the active ingredient in Wegovy and Ozempic, lowers major cardiac event risk, regardless of how much weight a ...

An analysis found that a shrinking waist size was responsible for only around a third of the cardiovascular benefits in ...

As more Americans turn to GLP-1 medications like Ozempic and Wegovy, restaurants are shrinking portions, reworking menus, and reimagining what a satisfying meal looks like.

Cities around the world are losing residents, and it’s creating serious social and economic challenges. This video explores the main reasons behind shrinking urban areas. Hurricane Melissa close to ...

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) currently available for the treatment of obesity are administered as a peptide-based subcutaneous injection, but oral (non-peptide) versions would ...

The pill could offer an alternative to weekly injections of GLP-1 drugs WEDNESDAY, Sept. 24, 2025 (HealthDay News) — A pill form of the blockbuster weight-loss drug Ozempic can help overweight or ...

Ozempic Insulin box and injection pen or insulin cartridge pen for diabetes patients from Novo Nordisk. Blurred pharmacy background. Copenhagen, Denmark - January 29, 2024. A semaglutide pill is ...

A massive international study has shown that the experimental oral obesity drug orforglipron can help patients shed over 10% of their body weight, with nearly one in five losing 20% or more. Unlike ...

An oral weight loss pill has performed well in clinical trials, positioning it as a potential alternative to injectable GLP-1 medications like Ozempic and Wegovy. The Eli Lilly drug, called ...